Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (Varilrix™) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine
Varicella Vaccine
100388
NCT00226499
Varicella
Phase 3
 
Follow up studies 103494,104105, and 104106 were conducted. The results of this study 100388 are summarized with studies 103494, 104105, and 104106 on the GSK Clinical Study Register. An annotated case report form is not available for this study. An annotated case report form is not available for this study. A blank case report form will be provided.
February 2015

Powered by ideaPoint, Inc.